(Q43640001)

25 November 2017

Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo (English)

1 reference

25 November 2017

Vandergriff J

1

1 reference

25 November 2017

Huff K

series ordinal

2

1 reference

25 November 2017

Bond A

series ordinal

3

1 reference

25 November 2017

Lodge D

series ordinal

4

1 reference

25 November 2017

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

40

1 reference

25 November 2017

8

1 reference

25 November 2017

1003-1009

1 reference

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

A centrally active drug that modulates AMPA receptor gated currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Effect of AMPA receptor modulators on hippocampal and cortical function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Neuropharmacology of AMPA and kainate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

A synaptic model of memory: long-term potentiation in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Effects of piracetam on the performance of rats in a delayed match-to-position task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Long-term potentiation in the hippocampus using depolarizing current pulses as the conditioning stimulus to single volley synaptic potentials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Enhancement by an ampakine of memory encoding in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Magnesium gates glutamate-activated channels in mouse central neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Effect of the nootropic drug oxiracetam on field potentials of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Different susceptibilities of long-term potentiations in CA3 and CA1 regions of guinea pig hippocampal slices to nootropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Are glutamate receptors specifically implicated in some forms of memory processes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900031-4

10.1016/S0028-3908(01)00031-4

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference